Please assess the completion status of the following clinical trial:

Trial Title: A Post Marketing Surveillance (PMS) Study of Liraglutide in Subjects With Type 2 Diabetes Mellitus in India

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Subjects with type 2 diabetes, including newly-diagnosed patients / those already receiving other anti-diabetic medications including GLP-1 analogues, who require treatment with liraglutide according to the clinical judgment of their treating physician~* Subjects who are capable of giving study-specific signed informed consent before any collection of information~Exclusion Criteria:~* Subjects with type 1 diabetes~* Subjects who are or have previously been on liraglutide~* Subjects who have previously been enrolled in the study~* Subjects who are participating in another clinical trial~* Subjects with a hypersensitivity to liraglutide or to any of the excipients (Disodium phosphate dihydrate, propylene glycol, phenol, water for injections)~* Subjects who are pregnant, breast feeding or have the intention of becoming pregnant within the following 6 months

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).